News

Market Shifts in Platinum Trading Following China Tax Changes

Market Shifts in Platinum Trading Following China Tax Changes

Platinum Prices Surge Amid Market Volatility

Platinum has recently emerged as a hot topic in the precious metals market, showcasing remarkable volatility. Just when the market was still adjusting to the earlier dips in gold and silver prices, platinum made a significant move by rising 6.4%, reaching $1,646 per ounce in the spot market. This surge marks the most substantial intraday increase for platinum since 2020, signaling considerable shifts in investor sentiment.

Futures and Physical Market Discrepancies

While futures prices also increased by 4.1%, a rare gap between physical and paper markets appeared. Notably, the London spot premium over Nymex futures expanded to over $53 per ounce, nearly double the previous day's amount. Typically, these two markets operate in tandem, so this divergence indicates a heightened demand for physical platinum, prompting investors to act swiftly.

The Chinese Tax Policy Shift

This dramatic surge occurred shortly after significant changes in taxation policy by Chinese authorities. China, being the largest consumer of platinum, announced a phase-out of a two-decade-old value-added tax refund starting November 1. This news reverberated through global markets, as it alters the competitive landscape within the platinum sector.

The Impact of VAT Changes

Prior to this announcement, China Platinum Co. enjoyed a significant competitive edge, being the sole importer of platinum exempt from the 13% VAT. The removal of this exemption is seen as a pivotal moment for China's platinum market, highlighting the previously uneven playing field that favored this state-run firm.

Reactions from Market Experts

Weibin Deng, the Asia-Pacific head at the World Platinum Investment Council (WPIC), expressed that the dissolution of the tax exemption is a major shift for the platinum market in China, potentially leveling the playing field for other competitors who have long faced disadvantages due to this policy.

Experts anticipate that removing the rebate will amplify premiums in Shanghai over global prices, potentially encouraging buyers to procure platinum ahead of the policy's implementation, thus tightening global market conditions even further.

Current Supply Conditions and Market Performance

The existing supply constraints in the platinum market are not a new phenomenon. In 2025, platinum has surfaced as one of the hottest commodities, driven largely by increased investment and jewelry purchasing in China. Simultaneously, banks in London are facing challenges due to dwindling inventories, adding to the growing competition for available supply.

The Supply Chain Struggles

The primary challenge facing the platinum market is the concentrated and declining supply of mined platinum. South Africa dominates production, contributing almost 90% of the output in 2024. The Bushveld Igneous Complex, which accounts for about 75% of the world's known platinum reserves, underscores the significant reliance on a single geographic source.

Future Demand Projections

WPIC chief Trevor Raymond has warned about the structural deficit in the platinum market, fueled by robust demand growth particularly in China. The expected continuation of high demand patterns in the jewelry sector and investment products may not necessarily translate into increased supply. Even with higher prices intended to stimulate production, platinum inventories have not shown significant recovery. WPIC forecasts suggest that demand will consistently outpace supply throughout this decade.

Moreover, platinum's role as a critical component in hydrogen technologies and laboratory settings further emphasizes its importance in future market shifts.

Investment Insights

For investors, it's worth noting the performance of the abrdn Physical Platinum Shares ETF (NYSE:PPLT), which has witnessed a remarkable increase of 78.33% year-to-date, signaling the growing investor interest in this precious metal.

Frequently Asked Questions

What caused the recent increase in platinum prices?

The surge in platinum prices was significantly influenced by China's announcement to phase out an existing VAT rebate on platinum imports, disrupting market dynamics.

How has the VAT change affected Chinese companies?

The removal of the VAT rebate is expected to provide a more competitive environment for various companies in China, previously hampered by the competitive advantage of the sole importer, China Platinum Co.

What are the implications of the platinum supply levels?

Supply levels remain a concern, as almost 90% of platinum production comes from South Africa. This reliance on a single region poses risks for market stability.

What is the outlook for platinum demand in the coming years?

Market analysts suggest that platinum demand will continue to outstrip supply throughout the decade, driven by strong growth in jewelry and investment sectors.

How has PPLT performed in the market?

The abrdn Physical Platinum Shares ETF (NYSE:PPLT) has gained significant traction, reflecting a 78.33% uptick year-to-date, indicating robust investor confidence in platinum.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 50

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 84

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Equitage Ventures Launches $47.3M Fund for Senior Care Tech

Updated Category News Views 329

Equitage Ventures Launches Significant Investment Fund Equitage Ventures, an early-stage venture capital firm dedicated to AgeTech, has announced the successful final closing of a substantial $47.3 million investment fund. This fund is designed to provide critical capital, distribution resources, and strategic guidance to innovative entrepreneurs who aim to tackle the...

Continue Reading
Understanding Market Trends: Insights into Chevron Corp's Performance

Updated Category News Views 171

Chevron Corp Market Sentiment Analysis Chevron Corp (NYSE: CVX) has experienced a noteworthy decline in its short interest as a percentage of float, showing a 10.26% decrease since its previous report. Currently, there are approximately 14.02 million shares sold short, which accounts for 0.7% of all shares available for trading. Given the trading volume, it is estimated...

Continue Reading
Establishment of Blakely McCrory Hope Fund at Moody Gardens

Updated Category News Views 200

Introducing the Blakely McCrory Hope Fund Moody Gardens is proud to announce a special initiative to honor the memory of a young girl who captured the hearts of many: the Blakely McCrory Hope Fund. This fund has been established in loving memory of 8-year-old Blakely McCrory, who lost her life in a tragic flooding incident that occurred during the summer months....

Continue Reading
Star-Studded Table Read of 'It's a Wonderful Life' Event

Updated Category News Views 221

Exciting Holiday Table Read for a Worthy Cause The Ed Asner Family Center is pulling out all the stops this holiday season with an exciting virtual table read of the beloved classic, "It's a Wonderful Life." Scheduled for December 14 at 5 PM PST, this event promises to spread joy while supporting individuals and families with special needs. Star-Studded Cast Comes...

Continue Reading
Transforming $100 Into Over $1700 with Monolithic Power Systems

Updated Category News Views 145

Understanding the Growth of Monolithic Power Systems Monolithic Power Systems (NASDAQ: MPWR) has showcased impressive financial performance over the past decade, outperforming many market benchmarks. With an impressive annualized growth rate of 19.88%, it has attracted the attention of savvy investors. The Power of Compounded Returns Imagine investing $100 in MPWR stock...

Continue Reading